[go: up one dir, main page]

NO20021832L - Farmasöytiske sammensetninger av tizoksanid og nitazoksanid - Google Patents

Farmasöytiske sammensetninger av tizoksanid og nitazoksanid

Info

Publication number
NO20021832L
NO20021832L NO20021832A NO20021832A NO20021832L NO 20021832 L NO20021832 L NO 20021832L NO 20021832 A NO20021832 A NO 20021832A NO 20021832 A NO20021832 A NO 20021832A NO 20021832 L NO20021832 L NO 20021832L
Authority
NO
Norway
Prior art keywords
tizoxanide
nitazoxanide
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
NO20021832A
Other languages
English (en)
Other versions
NO335781B1 (no
NO20021832D0 (no
Inventor
Jean-Francois Rossignol
Original Assignee
Romark Lab Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20021832(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/852,447 external-priority patent/US5968961A/en
Priority claimed from US08/887,809 external-priority patent/US5965590A/en
Priority claimed from US08/887,810 external-priority patent/US5856348A/en
Publication of NO20021832L publication Critical patent/NO20021832L/no
Application filed by Romark Lab Lc filed Critical Romark Lab Lc
Publication of NO20021832D0 publication Critical patent/NO20021832D0/no
Publication of NO335781B1 publication Critical patent/NO335781B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • A61P33/12Schistosomicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20021832A 1997-05-07 2002-04-18 Farmasøytiske sammensetninger av tizoksanid og nitazoksanid NO335781B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,809 US5965590A (en) 1994-09-08 1997-07-03 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en) 1994-09-08 1997-07-03 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
PCT/US1998/009229 WO1998050035A1 (en) 1997-05-07 1998-05-06 Pharmaceutical compositions of tizoxanide and nitazoxanide

Publications (3)

Publication Number Publication Date
NO20021832L true NO20021832L (no) 2000-01-04
NO20021832D0 NO20021832D0 (no) 2002-04-18
NO335781B1 NO335781B1 (no) 2015-02-16

Family

ID=27420362

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19995406A NO313983B1 (no) 1997-05-07 1999-11-04 Farmasöytiske sammensetninger av tizoksanid og nitazoksanid
NO20021832A NO335781B1 (no) 1997-05-07 2002-04-18 Farmasøytiske sammensetninger av tizoksanid og nitazoksanid

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19995406A NO313983B1 (no) 1997-05-07 1999-11-04 Farmasöytiske sammensetninger av tizoksanid og nitazoksanid

Country Status (34)

Country Link
EP (2) EP1222921B1 (no)
JP (1) JP3739802B2 (no)
KR (2) KR100576646B1 (no)
CN (2) CN100515420C (no)
AP (1) AP1103A (no)
AR (1) AR057242A2 (no)
AT (2) ATE228839T1 (no)
AU (1) AU740022B2 (no)
BG (2) BG109365A (no)
BR (1) BR9808722A (no)
CA (2) CA2418634C (no)
CZ (2) CZ298270B6 (no)
DE (2) DE69809928T2 (no)
DK (2) DK1005342T3 (no)
EA (2) EA002920B1 (no)
EE (1) EE04870B1 (no)
ES (2) ES2150404T3 (no)
GE (1) GEP20032970B (no)
HU (1) HU229641B1 (no)
IL (2) IL155799A (no)
IS (1) IS2087B (no)
LV (1) LV12492B (no)
ME (1) ME00530B (no)
NO (2) NO313983B1 (no)
NZ (2) NZ513881A (no)
OA (1) OA11169A (no)
PL (1) PL193275B1 (no)
PT (2) PT1222921E (no)
RO (1) RO120605B1 (no)
SI (1) SI20149B (no)
SK (2) SK283947B6 (no)
TR (1) TR199902733T2 (no)
UA (2) UA57079C2 (no)
WO (1) WO1998050035A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
EA015560B1 (ru) 2006-01-09 2011-08-30 Ромарк Лэборетериз, Эл.Си. Способ лечения вирусного гепатита
HUE049501T2 (hu) * 2009-02-13 2020-09-28 Romark Laboratories Lc Nitazoxanidot tartalmazó szabályozott felszabadulású gyógyszerkészítmény
CA2940954A1 (en) 2009-05-12 2010-11-18 Romark Laboratories L.C. Nitazoxanide and tizoxanide for the treatment of rhinovirus and rhabdovirus infections
MX341877B (es) 2009-06-26 2016-09-06 Romark Laboratories L C * Compuestos y métodos para tratar influenza.
US9498441B2 (en) 2012-01-27 2016-11-22 Siegfried Rhein S.A. De C.V. Nitazoxadine composition and process to prepare same
BR112017009651A2 (pt) * 2014-11-11 2017-12-19 Romark Laboratories Lc composto, composição farmacêutica, e, método para tratamento de uma infecção por protozoário intracelular, uma infecção viral ou um câncer.
US20210113457A1 (en) 2018-02-02 2021-04-22 Ripple Therapeutics Corporation Glass formulations and uses thereof
WO2019241376A1 (en) 2018-06-14 2019-12-19 The Trustees Of Columbia University In The City Of New York Treatment of cognitive disorders using nitazoxanide (ntz), nitazoxanide (ntz) analogs, and metabolites thereof
WO2020154815A1 (en) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
EP4010347A4 (en) 2019-08-07 2023-09-20 Ripple Therapeutics Corporation COMPOSITIONS AND METHODS FOR TREATING PAIN AND ADDICTION DISORDERS
MX2022013665A (es) 2020-05-01 2022-11-30 Ripple Therapeutics Corp Composiciones y metodos heterodimeros para el tratamiento de trastornos oculares.
WO2022130406A1 (en) * 2020-12-15 2022-06-23 Cipla Limited Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives

Also Published As

Publication number Publication date
IL155799A0 (en) 2003-12-23
UA57079C2 (uk) 2003-06-16
CN100515420C (zh) 2009-07-22
ME00530B (me) 2011-10-10
CN1255060A (zh) 2000-05-31
IL132516A0 (en) 2001-03-19
NZ500149A (en) 2001-11-30
EP1222921A1 (en) 2002-07-17
BG109365A (en) 2006-08-31
NO313983B1 (no) 2003-01-13
CZ298270B6 (cs) 2007-08-08
CZ298269B6 (cs) 2007-08-08
AP9901675A0 (en) 1999-12-31
CA2418634C (en) 2004-10-26
SK283946B6 (sk) 2004-05-04
ES2232687T3 (es) 2005-06-01
BG64973B1 (bg) 2006-11-30
CN1158074C (zh) 2004-07-21
CN1552322A (zh) 2004-12-08
PL336805A1 (en) 2000-07-17
EP1005342A1 (en) 2000-06-07
KR20040004544A (ko) 2004-01-13
HK1025907A1 (en) 2000-12-01
CA2288003A1 (en) 1998-11-12
HUP0003330A3 (en) 2002-10-28
JP3739802B2 (ja) 2006-01-25
IL132516A (en) 2003-12-10
CA2418634A1 (en) 1998-11-12
CA2288003C (en) 2003-10-21
DE69809928T2 (de) 2003-04-24
NO995406L (no) 2000-01-04
LV12492B (en) 2001-01-20
PT1222921E (pt) 2005-02-28
AR057242A2 (es) 2007-11-21
BG103958A (en) 2000-07-31
JP2001503067A (ja) 2001-03-06
KR20010020322A (ko) 2001-03-15
UA74388C2 (uk) 2005-12-15
CZ391199A3 (cs) 2000-07-12
EE9900578A (et) 2000-08-15
NO335781B1 (no) 2015-02-16
EE04870B1 (et) 2007-08-15
AU7289598A (en) 1998-11-27
SK151199A3 (en) 2000-07-11
EA002920B1 (ru) 2002-10-31
HU229641B1 (en) 2014-03-28
EA002908B1 (ru) 2002-10-31
EA199901012A1 (ru) 2000-08-28
WO1998050035A1 (en) 1998-11-12
SK283947B6 (sk) 2004-05-04
SI20149B (en) 2001-08-31
EP1005342B1 (en) 2002-12-04
NO995406D0 (no) 1999-11-04
DK1222921T3 (da) 2005-03-07
DE69827417D1 (de) 2004-12-09
EA200100956A1 (ru) 2002-02-28
OA11169A (en) 2003-04-25
TR199902733T2 (xx) 2000-03-21
ATE228839T1 (de) 2002-12-15
LV12492A (en) 2000-06-20
DE69827417T2 (de) 2005-10-27
ES2150404T3 (es) 2003-07-01
NZ513881A (en) 2002-10-25
PL193275B1 (pl) 2007-01-31
GEP20032970B (en) 2003-05-27
HUP0003330A2 (hu) 2001-05-28
IS5223A (is) 1999-10-19
NO20021832D0 (no) 2002-04-18
AP1103A (en) 2002-09-04
AU740022B2 (en) 2001-10-25
KR100426657B1 (ko) 2004-04-13
EP1222921B1 (en) 2004-11-03
DE69809928D1 (de) 2003-01-16
SI20149A (sl) 2000-08-31
DK1005342T3 (da) 2003-03-24
PT1005342E (pt) 2003-02-28
RO120605B1 (ro) 2006-05-30
BR9808722A (pt) 2000-07-11
KR100576646B1 (ko) 2006-05-08
IS2087B (is) 2006-03-15
EP1005342A4 (en) 2001-02-07
ATE281166T1 (de) 2004-11-15
IL155799A (en) 2004-08-31
ES2150404T1 (es) 2000-12-01

Similar Documents

Publication Publication Date Title
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
IL135589A0 (en) Aminothiazole derivatives and pharmaceutical compositions containing the same
LT99141A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
NO984094D0 (no) Utladningsreaktor og anvendelse av samme
HUP9902655A3 (en) Pharmaceutical composition of hedgehog proteins and use thereof
HUP0100149A3 (en) Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use
HU9800147D0 (en) Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them
NO995406D0 (no) Farmasöytiske sammensetninger av tizoksanid og nitazoksanid
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
BR9509688A (pt) Composto e composição farmacêutica
PT1140110E (pt) Clatratos de desidroepiandrosterona e correspondentes composicoes farmaceuticas
FI971427A7 (fi) Peptidit ja niitä sisältävät farmaseuttiset koostumukset
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
EP0996441A4 (en) PHARMACEUTICAL COMPOSITIONS OF ARGLABIN AND ARGLABIN DERIVATIVES
HUP9900251A3 (en) Pharmaceutical compositions containing hedgehog proteins and use of former compositions
ZA995006B (en) Pharmaceutical composition of hedgehog proteins and use thereof.
BR9605220A (pt) Gonadotropinas e composiçao farmacêutica
BR9505130A (pt) Composto e composiçao farmacêutica
HUP0003827A3 (en) Cyanoamidine derivatives and pharmaceutical compositions containing them
SE9703737D0 (sv) Pharmaceutical composition and use
DK1014951T3 (da) Farmaceutisk coatingssammensætning og fremgangsmåde til anvendelse
BR1101151A (pt) Compostos e composição farmacêutica
ZA99887B (en) Pharmaceutical composition of hedgehog proteins and use thereof.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees